Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01292629
Recruitment Status : Completed
First Posted : February 9, 2011
Results First Posted : March 20, 2015
Last Update Posted : March 20, 2015
Information provided by (Responsible Party):
Hoya Surgical Optics, Inc.

Brief Summary:
The purpose of this multi-center clinical trail is to determine the safety and efficacy of the iSert 251 for the correction of aphakia.

Condition or disease Intervention/treatment Phase
Aphakia Cataract Device: iSert 251 intraocular lens Not Applicable

Detailed Description:
This study evaluated the safety and effectiveness of the Hoya Surgical Optics iSert Model 251 IOL following primary implantation for the visual correction of aphakia in adults in whom the cataractous lens has been removed by phacoemulsification. Results from this prospective, multicenter clinical trial will be used to support a PMA supplement for the iSert® 251 IOL.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 125 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.
Study Start Date : February 2011
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012

Arm Intervention/treatment
Experimental: Investigational intraocular lens
iSert 251 intraocular lens
Device: iSert 251 intraocular lens
aphakic intraocular lens

Primary Outcome Measures :
  1. Visual Acuity [ Time Frame: 4 to 6 months ]
    BEST Spectacle-Correction (ETDRS) Distance Visual Acuity

Secondary Outcome Measures :
  1. Complications and Adverse Events [ Time Frame: 4 to 6 months ]
    Number of Participants with Complications or Adverse Events

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Have been diagnosed with cataract for which phacoemulsification extraction and posterior chamber IOL implantation is indicated
  • Have clear intraocular media
  • Have potential Best Corrected Visual Acuity of 20/40 or better
  • Have preoperative Best Spectacle-Corrected visual acuity of 20/40 or worse

Exclusion Criteria:

  • Have ocular pathology or abnormalities that do or are expected to reduce best corrected visual acuity in the operative eye during the study period
  • Are monocular
  • Have current ocular infection
  • Are taking systemic steroids or other anti-metabolites
  • Have previous retinal detachment in the operative eye or expect to require retinal laser treatment during the course of the study

Eligibility criteria not complete. Contact Hoya Surgical Optics, Inc. for more information.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01292629

United States, Arizona
Schwartz Laser Eye Center
E. Shea Blvd, Suite C101, Arizona, United States, 85260
United States, Florida
Katzen Eye Care and Laser Center
Boynton Beach, Florida, United States, 33426
Center for Excellence in Eye Care
Miami, Florida, United States, 33176
United States, Indiana
Eye Surgeons of Indiana
Indianapolis, Indiana, United States, 46256
United States, Massachusetts
Eye Health Vision Centers
North Dartmouth, Massachusetts, United States, 02747
Sponsors and Collaborators
Hoya Surgical Optics, Inc.
Study Director: Kees den Besten Hoya Surgical Optics

Responsible Party: Hoya Surgical Optics, Inc. Identifier: NCT01292629     History of Changes
Other Study ID Numbers: 2010-N251
First Posted: February 9, 2011    Key Record Dates
Results First Posted: March 20, 2015
Last Update Posted: March 20, 2015
Last Verified: March 2015

Keywords provided by Hoya Surgical Optics, Inc.:
intraocular lens
visual acuity

Additional relevant MeSH terms:
Lens Diseases
Eye Diseases